INS and type 1 diabetes mellitus: In this context, our work aims to analyze the most recent technologies regarding continuous glucose monitors (CGMs) and continuous subcutaneous insulin infusion (CSII) systems, their psychosocial impact [47], and their capacity to improve T1DM patients’ life quality [48] in a narrative review.